Spectral AI

About:

Spectral AI specializes in predictive analytics with a platform that uses proprietary artificial intelligence (AI).

Website: https://www.spectral-ai.com/

Twitter/X: Spectral_MD

Top Investors: Biomedical Advanced Research and Development Authority (BARDA), Medical Technology Enterprise Consortium

Description:

Spectral AI, Inc. is a predictive analytics company that develops proprietary AI algorithms and optical technology for wound healing predictions. Using its DeepView® Wound Imaging Solution, an internally developed AI technology and multispectral imaging system which has received FDA Breakthrough Designation for burn indication, Spectral AI is able to distinguish between non-healing and healing human tissue invisible to the naked eye. Spectral AI is working towards providing 'Day One' healing assessments for burn wounds and diabetic foot ulcers (DFU) using its DeepView® Wound Imaging Solution.

Total Funding Amount:

$110M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Dallas, Texas, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)spectral-ai.com

Founders:

J. Michael DiMaio, Wensheng Fan

Number of Employees:

101-250

Last Funding Date:

2024-11-19

IPO Status:

Public

Industries:

© 2025 bioDAO.ai